CovationBio mass produces Xatryx bioPTMEG
Analysis based on 6 articles · First reported Sep 02, 2026 · Last updated Sep 02, 2026
The successful mass production and product launch could strengthen CovationBio's market position in sustainable bio-based materials, potentially attracting customers seeking eco-friendly alternatives. However, as a private company, direct market impact is limited, though it may influence the broader chemicals and footwear industries by showcasing viable non-food bio-based feedstocks.
Covation Biomaterials LLC (CovationBio) announced successful production of its first commercial on-spec batches of Xatryx.T bioTHF and Xatryx bioPTMEG at its new 50,000-ton Qidong plant in China. The plant reached mechanical completion in April 2026 and began commercial production in August 2026, with all three molecular weight grades (2000, 1800, 1000) meeting quality specifications. Concurrently, CovationBio partnered with insole brand INSITE to unveil the world's first partially non-food bio-based athletic insole using Xatryx bioPTMEG at the NW Materials Show in Portland, Oregon, on September 2-3, 2026. The bio-based materials are derived from annually renewable non-food biomass such as corncobs, offering lower greenhouse gas emissions and reduced reliance on fossil fuels. The company highlighted the drop-in capability of Xatryx bioPTMEG to replace fossil-based PTMEG in applications like spandex, polyurethanes, and thermoplastic elastomers. CovationBio, established in 2022 and headquartered in Newark, Delaware, builds on DuPont's innovation legacy and also markets Sorona. The event marks a milestone in scaling up bio-based materials production and demonstrating their application in consumer footwear.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard